Pharmafile Logo

Consumation Ltd

Consumation produce highly usable documents, instructions, leaflets and forms. There’s more to a great leaflet than meets the eye. Our experts know the trade secrets of layout, typography and plain language and avoiding jargon – and they’re well versed in the research evidence on patients’ information preferences. Our in-house designers specialise in world-class information layout and typography. Trust them to find an innovative solution! You’ll be surprised at the range of stuff we’ve done: consent sheets, educational and professional materials, research papers, forms and newsletters. Oh, and we’ve worked on a few hundred other instruction leaflets.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

53 Hosack Road, London, SW17 7QW, United Kingdom
+44 (0)20 8673 4403

 Latest Content from PMHub 

Patient Assistance Programme Evaluation for Cardiovascular Conditions

Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product.Read the case...

What next for the treatment of Psoriasis in Europe?

Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.

The driving force behind Momentum Strategy

An internet search on what makes a business successful delivers countless promises to reveal the secrets behind sustained growth. The strategies of well-known companies provide valuable case studies that have...

20 questions: Round 1

As it's our 20th year anniversary, we invited our employees to play 20 questions - this month "What's the biggest challenge you've overcome at Research Partnership?"Watch the video: https://www.researchpartnership.com/news/2017/03/20-questions-round-1/

Brand tracking research

A common challenge for brand tracking is ensuring the research programme stays relevant to the brand’s current environment. In this video Quantitative Research Directors Karen Swords and Vicky McLellan outline...

Wilmington Healthcare launches new, integrated, digital channel to help pharma engage with the NHS

Healthcare intelligence provider Wilmington Healthcare has integrated its tools and resources online to help pharma navigate changes within the NHS, following the official launch of Sustainability and Transformation Plans (STPs)....

Lucid Partners US changes its name to Lighthouse Medical Communications US

With immediate effect Lucid Partners US will change its name to Lighthouse Medical Communications US.The demand for the Lucid Group services in the US has grown rapidly, and by creating a...

Using service design to improve patients’ quality of life

Customer Experience Consultant Eimear Power talks through the process of developing Orello, a service for metastatic prostate cancer patients and their loved ones, in collaboration with Janssen.

Precision medicine and the changing role of the healthcare professional

The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...

How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma